A timeline going forward would be greatly appreciated, page-19

There is so much more Anteris can tackle to increase its Market Value, however it has to crawl as so to speak before it runs. We may be in for a wait.

Edwards is making significant investments in the development of a differentiated portfolio of therapy options designed to treat mitral and tricuspid valve diseases.

Provided research into these areas as well those all ready on the drawing board, will imo transform this tiny unknown company of ours, into one of the worlds giant conglomerate, alongside the likes of other giants.

It is imo worth what your imagination can believe it’s capable of achieving. No more discounts for future funding. If those wanting to invest can’t see the big picture, then they should seek beer money, somewhere else.

Have a great weekend all.